Advances in Cancer Prevention
Open Access
Aromatase Inhibitors
Search results for
Aromatase Inhibitors
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Recommended Conferences
42nd Global Conference on Nursing Care & Patient Safety
Toronto, CanadaGoogle Scholar citation report
Citations : 352
Advances in Cancer Prevention received 352 citations as per Google Scholar report
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Aromatase Inhibitors
Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer and ovarian cancer in postmenopausal women and swelling of breast tissue in men. They may also be used off-label to reduce increase of oestrogen conversion during cycle with external testosterone. They may also be used for chemoprevention in high risk women.
Aromatase Inhibitors related journals
Advances in Cancer Prevention, Cancer Science & Therapy, Cervical Cancer: Open Access, Colorectal Cancer: Open Access, Gastrointestinal Cancer and Stromal Tumors, World Journal of Cancer Research, International Journal Of Cancer Research, Journal of Cancer Education, Journal for ImmunoTherapy of Cancer, Journal of Cancer Biology & Research.
Aromatase Inhibitors
Expert PPTs
- You Mie Lee
Cell signalling and Biochips
PPT Version | PDF Version
Speaker PPTs
- Sruthi Ramagiri
Beneficial neuroprotective effect of GSK-3ò inhibitors against brain stroke and associated cognitive impairments in diabetic rats
PPT Version | PDF Version - Maria A. Miteva
In silico screening to discover inhibitors of protein-protein interactions targeting angiogenesis
PPT Version | PDF Version - X James Li
A simple and rapid assay for determination of susceptibility of influenza virus to neuraminidase inhibitors
PPT Version | PDF Version - Dalia Hussein Soliman
ââ¬ÅDalia Hussein Soliman-Al-Azhar-University-Egypt-Design-synthesis-docking-and-QSAR-studies-of-novel-3-5-diaryl-pyrazole-derivatives-and-their-evaluation-as-antioxidants-and-as-Immunomodulators-inhibitors-of-TNF-ñ-IL-2-IL-6ââ¬Â
PPT Version | PDF Version - T Chris Gamblin
T-Chris-Gamblin-University-of-Kansas-USA-Mining-the-A.-nidulans-metabolome-for-tau-aggregation-inhibitors
PPT Version | PDF Version - Asad U Khan
Inhibitors against Resistant markers: a Molecular and computational Biology approach
PPT Version | PDF Version - Hayam I Gad
Effects of Pravastatin or 12/15 lipoxygenase pathway inhibitors on indices of Diabetic nephropathy in an experimental model of diabetic renal disease
PPT Version | PDF Version - Joanna Trojanek
Metalloproteinases and their inhibitors gene expression profiles in leukocytes of primary hypertension (PH), non-alcoholic fatty liver disease (NAFLD), and obese children
PPT Version | PDF Version - Weijia Xie
Recent structure relationship studies (SAR) on natural occurring sulfonium salts as potent ï¡-glucosidase inhibitors
PPT Version | PDF Version - Lauren D. Bailey
Mode of Action of the Sulfhydryl Group in Virolytic Peptide Triazole Thiol Inhibitors of HIV-1 Env
PPT Version | PDF Version - Zuping Xia
Development of Sphingosine Kinase Inhibitors for Cancer Therapy
PPT Version | PDF Version - Syed Khajamohiddin
Engineering of cytochrome P450 monooxygenases-based novel inhibitors against Mycobacterium tuberculosis
PPT Version | PDF Version - Ruben Artero
A Drosophila high-throughput drug screening platform identifies inhibitors of misregulated alternative splicing events in myotonic dystrophy
PPT Version | PDF Version